XML 44 R36.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF ERROR CORRECTIONS (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Total assets $ 2,004,466   $ 5,620,989   $ 2,004,466 $ 5,620,989 $ 2,914,629  
Total current liabilities 1,994,242   1,381,419   1,994,242 1,381,419 688,671  
Additional paid-in capital 42,028,310   41,032,001   42,028,310 41,032,001 41,596,032  
Accumulated deficit (42,018,169)   (36,792,509)   (42,018,169) (36,792,509) (39,370,153)  
Other     78     78    
Total stockholders’ equity 10,223 $ 1,125,029 4,239,570 $ (14,031,887) 10,223 4,239,570 2,225,958 $ (12,831,606)
Total liabilities and stockholders’ equity 2,004,466   5,620,989   2,004,466 5,620,989 2,914,629  
Gross profit (loss)     (3,573)     (11,279)    
Sales and marketing     124,759     194,067    
Research and development 250,006   353,226   454,405 558,029    
General and administrative 946,175   1,731,190   1,753,774 2,222,473    
Total operating expenses 1,403,971   2,209,175   2,593,253 2,974,569    
Total other income (expense) (58,356)   (1,342,114)   (60,552) (1,505,102)    
Net income (loss) (1,464,557) $ (1,183,460) (3,554,862) $ (936,088) (2,648,017) (4,490,950)    
Net (loss) allocable to common stockholders $ (1,464,557)   $ (3,683,070)   $ (2,648,017) $ (4,906,473)    
Earnings Per Share, Basic $ (0.18)   $ (0.47)   $ (0.33) $ (1.12)    
Earnings Per Share, Diluted $ (0.18)   $ (0.47)   $ (0.33) $ (1.12)    
Weighted Average Number of Shares Outstanding, Basic 8,287,669   7,821,515   8,119,982 4,373,668    
Weighted Average Number of Shares Outstanding, Diluted 8,287,669   7,821,515   8,119,982 4,373,668    
Depreciation and amortization         $ 79,809 $ 69,705    
Non-cash charge settled in equity           1,299,507    
Prepaids and other current assets         33,287 (448,434)    
Accrued and other liabilities           (193,320)    
Other           1,047,540    
Net cash (used in) operations         (1,960,653) (2,715,951)    
Net cash (used in) investing activities         (72,634) (120,957)    
IPO Issuance costs         (85,000) (365,060)    
Others           6,552,318    
Net cash provided by financing activities         1,165,000 6,187,258    
Net cash increase (decrease) for period         (868,287) 3,350,350    
Common Stock $ 82   $ 78   $ 82 78 $ 79  
Previously Reported [Member]                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Total assets     5,620,989     5,620,989    
Total current liabilities     1,381,419     1,381,419    
Additional paid-in capital     41,184,654     41,184,654    
Accumulated deficit     (36,945,162)     (36,945,162)    
Other     78     78    
Total stockholders’ equity     4,239,570     4,239,570    
Total liabilities and stockholders’ equity     5,620,989     5,620,989    
Gross profit (loss)     (3,573)     (11,279)    
Sales and marketing     124,759     194,067    
Research and development     353,226     558,029    
General and administrative     1,883,843     2,375,126    
Total operating expenses     2,361,828     3,127,222    
Total other income (expense)     (1,342,114)     (1,505,102)    
Net income (loss)     (3,707,515)     (4,643,603)    
Net (loss) allocable to common stockholders     $ (3,835,723)     $ (5,059,126)    
Earnings Per Share, Basic     $ (0.49)     $ (1.16)    
Earnings Per Share, Diluted     $ (0.49)     $ (1.16)    
Weighted Average Number of Shares Outstanding, Basic     7,821,515     4,363,600    
Weighted Average Number of Shares Outstanding, Diluted     7,821,515     4,363,600    
Depreciation and amortization           $ 94,705    
Non-cash charge settled in equity           0    
Prepaids and other current assets           (308,052)    
Accrued and other liabilities           728,399    
Other           1,047,540    
Net cash (used in) operations           (3,081,011)    
Net cash (used in) investing activities           (120,957)    
IPO Issuance costs           0    
Others           6,552,318    
Net cash provided by financing activities           6,552,318    
Net cash increase (decrease) for period           3,350,350    
Common Stock     $ 78     78    
Revision of Prior Period, Adjustment [Member]                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Total assets     0     0    
Total current liabilities     0     0    
Additional paid-in capital     (152,653)     (152,653)    
Accumulated deficit     152,653     152,653    
Other     0     0    
Total stockholders’ equity     0     0    
Total liabilities and stockholders’ equity     0     0    
Gross profit (loss)     0     0    
Sales and marketing     0     0    
Research and development     0     0    
General and administrative     (152,653)     (152,653)    
Total operating expenses     (152,653)     (152,653)    
Total other income (expense)     0     0    
Net income (loss)     152,653     152,653    
Net (loss) allocable to common stockholders     $ 152,653     $ 152,653    
Earnings Per Share, Basic     $ 0.02     $ 0.04    
Earnings Per Share, Diluted     $ 0.02     $ 0.04    
Weighted Average Number of Shares Outstanding, Basic     0     10,068    
Weighted Average Number of Shares Outstanding, Diluted     0     10,068    
Depreciation and amortization           $ (25,000)    
Non-cash charge settled in equity           1,299,507    
Prepaids and other current assets           (140,382)    
Accrued and other liabilities           (921,718)    
Other           0    
Net cash (used in) operations           365,060    
Net cash (used in) investing activities           0    
IPO Issuance costs           (365,060)    
Others           0    
Net cash provided by financing activities           (365,060)    
Net cash increase (decrease) for period           0    
Common Stock     $ 0     $ 0